Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$268,610,016
-$25,156,165 QoQ
Shares Held
3,942,610
+1.9% QoQ
Ownership
4.75%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 88.7126801788663.ToString("F0")%
None 11.287319821133716.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. PTCT ranks #21 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $268,610,016 | 3,942,610 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $293,766,181 | 3,867,380 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $301,855,644 | 4,918,619 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $229,261,696 | 4,694,138 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $276,161,001 | 5,419,172 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $216,090,728 | 4,787,123 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $292,822,840 | 7,892,799 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $251,019,168 | 8,208,606 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $258,946,522 | 8,901,565 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $270,545,575 | 9,816,603 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $211,464,969 | 9,436,188 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $276,001,420 | 6,786,364 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $338,968,149 | 6,997,691 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $283,637,717 | 7,430,907 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $376,051,310 | 7,491,062 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $281,762,206 | 7,033,505 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $304,096,682 | 8,150,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $324,815,518 | 8,155,047 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $326,213,631 | 8,766,827 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $369,075,938 | 8,731,392 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $435,163,401 | 9,190,357 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $569,951,781 | 9,338,879 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $442,850,406 | 9,472,736 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $407,122,485 | 8,023,699 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $278,284,671 | 6,238,168 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||